Emtricitabine and tenofovir and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Emtricitabine and tenofovir and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and Tenofovir Disoproxil Fumarate
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine and tenofovir-Insulin glargine, recombinant Subcutaneous
- Emtricitabine and tenofovir-Insulin glulisine
- Emtricitabine and tenofovir-Insulin Glulisine (Cartridges and Pens)
- Emtricitabine and tenofovir-Insulin Glulisine (Vials)
- Emtricitabine and tenofovir-Insulin glulisine Subcutaneous
- Emtricitabine and tenofovir-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Emtricitabine and Tenofovir Alafenamide
- Insulin glargine and lixisenatide Subcutaneous-Emtricitabine and Tenofovir Disoproxil Fumarate
- Insulin glargine and lixisenatide Subcutaneous-Emtricitabine and Tenofovir Tablets
- Insulin glargine and lixisenatide Subcutaneous-Emtricitabine Capsules
- Insulin glargine and lixisenatide Subcutaneous-Emtricitabine Solution
- Insulin glargine and lixisenatide Subcutaneous-Emtricitabine, lopinavir, ritonavir, and tenofovir